These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32452543)

  • 1. Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data.
    Gui RY; Huang QS; Cai X; Wu J; Liu HX; Liu Y; Yang LH; Zhang JY; Cheng YF; Jiang M; Mao M; Fang MY; Liu H; Wang LR; Wang Z; Zhou HB; Lan H; Jiang ZX; Shen XL; Zhang L; Fan SJ; Li Y; Wang QF; Huang XJ; Zhang XH
    Br J Haematol; 2020 Oct; 191(2):269-281. PubMed ID: 32452543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
    Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
    J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
    Bendapudi PK; Hurwitz S; Fry A; Marques MB; Waldo SW; Li A; Sun L; Upadhyay V; Hamdan A; Brunner AM; Gansner JM; Viswanathan S; Kaufman RM; Uhl L; Stowell CP; Dzik WH; Makar RS
    Lancet Haematol; 2017 Apr; 4(4):e157-e164. PubMed ID: 28259520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.
    Sui J; Cao W; Halkidis K; Abdelgawwad MS; Kocher NK; Guillory B; Williams LA; Gangaraju R; Marques MB; Zheng XL
    Blood Adv; 2019 Dec; 3(24):4177-4186. PubMed ID: 31856267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age.
    Rottenstreich A; Dor S; Keren-Politansky A; Sarig G; Nadir Y; Ellis M; Spectre G; Kirgner I; Pikovsky O; Arad A; Dann EJ; Kalish Y
    J Thromb Thrombolysis; 2021 Jan; 51(1):187-193. PubMed ID: 32388825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and Monitoring of Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): Strategies to Improve Outcomes.
    Kucukyurt S; Eskazan AE
    J Blood Med; 2020; 11():319-326. PubMed ID: 33061729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the MONITOR model in a nationwide multicenter study.
    Huang QS; Zhu XL; Qu QY; Liu X; Zhang GC; Su Y; Chen Q; Liu FQ; Sun XY; Liang MY; Liu Y; Jiang M; Liu H; Feng R; Yao HX; Zhang L; Qian SX; Yang TH; Zhang JY; Shen XL; Yang LH; Hu JD; Huang RW; Jiang ZX; Wang JW; Zhang HY; Xiao Z; Zhan SY; Liu HX; Chang YJ; Jiang Q; Jiang H; Lu J; Xu LP; Zhang XH; Yin CH; Wang JL; Huang XJ; Zhang XH
    Am J Hematol; 2021 May; 96(5):561-570. PubMed ID: 33606900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Venous thrombo-embolism during immune-mediated thrombotic thrombocytopenic purpura is prevalent in patients with a prolonged treatment with therapeutic plasma exchange].
    Benhamou Y; Sauvètre G; Grangé S; Veyradier A; Coppo P
    Rev Med Interne; 2020 Dec; 41(12):809-813. PubMed ID: 32727695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in the use of plasma exchange and adjunctive therapies to treat immune-mediated thrombotic thrombocytopenic purpura.
    Picod A; Coppo P
    Expert Rev Hematol; 2019 Jun; 12(6):461-471. PubMed ID: 31092093
    [No Abstract]   [Full Text] [Related]  

  • 10. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
    Li A; Khalighi PR; Wu Q; Garcia DA
    J Thromb Haemost; 2018 Jan; 16(1):164-169. PubMed ID: 29064619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies.
    Mazepa MA; Park YA; Raval JS
    Transfus Med Rev; 2019 Oct; 33(4):248-255. PubMed ID: 31645275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura.
    Garraud O; Malot S; Herbrecht R; Ojeda-Uribe M; Lin JS; Veyradier A; Payrat JM; Liu K; Corash L; Coppo P
    Transfus Apher Sci; 2019 Dec; 58(6):102665. PubMed ID: 31740165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-Mediated Thrombotic Thrombocytopenic Purpura: A Narrative Review of Diagnosis and Treatment in Adults.
    Blennerhassett R; Curnow J; Pasalic L
    Semin Thromb Hemost; 2020 Apr; 46(3):289-301. PubMed ID: 32259874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States.
    Adeyemi A; Razakariasa F; Chiorean A; de Passos Sousa R
    Res Pract Thromb Haemost; 2022 Aug; 6(6):e12802. PubMed ID: 36176310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura.
    Roose E; Schelpe AS; Tellier E; Sinkovits G; Joly BS; Dekimpe C; Kaplanski G; Le Besnerais M; Mancini I; Falter T; Von Auer C; Feys HB; Reti M; Rossmann H; Vandenbulcke A; Pareyn I; Voorberg J; Greinacher A; Benhamou Y; Deckmyn H; Fijnheer R; Prohászka Z; Peyvandi F; Lämmle B; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
    Blood; 2020 Jul; 136(3):353-361. PubMed ID: 32356859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
    Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
    Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study.
    Schieppati F; Russo L; Marchetti M; Barcella L; Cefis M; Gomez-Rosas P; Caldara G; Carpenedo M; D'Adda M; Rambaldi A; Savignano C; Billio A; Bruno Franco M; Toschi V; Falanga A
    Am J Hematol; 2020 Aug; 95(8):953-959. PubMed ID: 32350923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.
    Bentley MJ; Wilson AR; Rodgers GM
    Vox Sang; 2013 Nov; 105(4):313-8. PubMed ID: 23662653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.
    Letchumanan P; Ng HJ; Lee LH; Thumboo J
    Rheumatology (Oxford); 2009 Apr; 48(4):399-403. PubMed ID: 19202160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.
    Jestin M; Benhamou Y; Schelpe AS; Roose E; Provôt F; Galicier L; Hié M; Presne C; Poullin P; Wynckel A; Saheb S; Deligny C; Servais A; Girault S; Delmas Y; Kanouni T; Lautrette A; Chauveau D; Mousson C; Perez P; Halimi JM; Charvet-Rumpler A; Hamidou M; Cathébras P; Vanhoorelbeke K; Veyradier A; Coppo P;
    Blood; 2018 Nov; 132(20):2143-2153. PubMed ID: 30201758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.